Recent Posts
Archives
IR Department client media highlights
August 31st, 2022
by
Cherie Hartley
Read More
Interview with Peter Devine, CEO of Uniseed
August 31st, 2022
by
Paul Langley
Read More
XPON CEO Matt Forman discusses Wondaris and how it integrates with Google
August 29th, 2022
by
Paul Langley
Read More
Kazia Therapeutics CEO Dr James Garner talks with SmallCaps about what's on the horizon
August 29th, 2022
by
Paul Langley
Read More
Interview with Assoc.Prof. Mathias Francois of Gertrude Biomedical
August 29th, 2022
by
Paul Langley
Read More
HaemaLogiX's Tertia Dex explains the KappaMab antibody
August 29th, 2022
by
Paul Langley
Read More
Race Oncology CSO Dr Daniel Tillett discusses the bright future for Zantrene
August 29th, 2022
by
Paul Langley
Read More
Mosquito-borne diseases in Australia - an interview with Dr David Foster, CEO of Island Pharmaceuticals
August 29th, 2022
by
Paul Langley
Read More
Podcast - IR Department talks with AdAlta CEO & MD, Dr Tim Oldham
Our Communications Director, Cherie Hartley, talks with AdAlta's CEO & M.D. Dr Tim Oldham at this year's Bioshares Biotech Summit, who takes us inside the mind of a biotech company. He discussed the importance of focus for a platform company, explains why making decisions on a day-to-day basis is so crucial for risk reduction and why they're investing in supporting core strategies as well as their target product profile.
July 4th, 2022
by
Cherie Hartley
Read More
- 1